Coagulation profile in severe COVID-19 patients: what do we know so far?
作者信息
Savioli Felicio, Rocha Leonardo Lima
机构信息
Skaggs School of Pharmacy, University of California San Diego, Califórnia, Estados Unidos.
Medicina Intensiva, Hospital Alemão Oswaldo Cruz, São Paulo, SP, Brasil.
出版信息
Rev Bras Ter Intensiva. 2020 Jun;32(2):197-199. doi: 10.5935/0103-507x.20200031. Epub 2020 Jun 24.
Abstract
摘要
相似文献
1
Coagulation profile in severe COVID-19 patients: what do we know so far?重症 COVID-19 患者的凝血情况：我们目前了解多少？
Rev Bras Ter Intensiva. 2020 Jun;32(2):197-199. doi: 10.5935/0103-507x.20200031. Epub 2020 Jun 24.
2
Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern?新型冠状病毒肺炎重症肺炎中的出血：异常凝血模式的另一面？
Eur J Intern Med. 2020 Jul;77:147-149. doi: 10.1016/j.ejim.2020.05.002. Epub 2020 May 7.
3
Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far?2019冠状病毒病（COVID-19）感染的皮肤表现——我们目前了解多少？
J Cutan Med Surg. 2020 Jul/Aug;24(4):416-417. doi: 10.1177/1203475420928375. Epub 2020 May 11.
4
Extracorporeal membrane oxygenation for acute respiratory distress syndrome in patients with coronavirus disease 2019: what do we know so far?2019冠状病毒病患者急性呼吸窘迫综合征的体外膜肺氧合：我们目前了解多少？
Perfusion. 2020 Sep;35(6):558-561. doi: 10.1177/0267659120934279. Epub 2020 Jun 24.
5
Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.新型冠状病毒肺炎住院患者中严重急性呼吸综合征冠状病毒2诱导的凝血病与预后：来自意大利的一则简讯
Thromb Haemost. 2020 Aug;120(8):1233-1236. doi: 10.1055/s-0040-1712918. Epub 2020 May 26.
6
[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].基于严重急性呼吸综合征（SARS）尸检的新型冠状病毒肺炎（COVID-19）分析
Zhonghua Bing Li Xue Za Zhi. 2020 Apr 8;49(4):291-293. doi: 10.3760/cma.j.cn112151-20200211-00114.
7
COVID-19 Coagulopathy: Considerations for Urologists.新型冠状病毒肺炎凝血功能障碍：泌尿外科医生的考量
J Urol. 2020 Oct;204(4):640-641. doi: 10.1097/JU.0000000000001144. Epub 2020 May 18.
8
[Determination Methods of 2019 Novel Coronavirus (SARS-CoV-2)].[2019新型冠状病毒（严重急性呼吸综合征冠状病毒2）的检测方法]
Zhongguo Yi Liao Qi Xie Za Zhi. 2020 Apr 8;44(4):359-362. doi: 10.3969/j.issn.1671-7104.2020.04.017.
9
[Research progress of coagulation dysfunction in coronavirus disease 2019].[新型冠状病毒肺炎凝血功能障碍的研究进展]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Sep;32(9):1135-1138. doi: 10.3760/cma.j.cn121430-20200426-00593.
10
Coagulation disorder in COVID-19.新型冠状病毒肺炎中的凝血功能障碍
Lancet Haematol. 2020 Sep;7(9):e630-e632. doi: 10.1016/S2352-3026(20)30218-0. Epub 2020 Jul 10.
引用本文的文献
1
D-dimer as a predictive and prognostic marker among COVID-19 patients.D-二聚体作为 COVID-19 患者的预测和预后标志物。
Saudi Med J. 2022 Jul;43(7):723-729. doi: 10.15537/smj.2022.43.7.20220213.
2
Blood coagulation parameter abnormalities in hospitalized patients with confirmed COVID-19 in Ethiopia.在埃塞俄比亚，住院的 COVID-19 确诊患者存在凝血参数异常。
PLoS One. 2021 Jun 21;16(6):e0252939. doi: 10.1371/journal.pone.0252939. eCollection 2021.
3
Functional capacity and rehabilitation strategies in Covid-19 patients: current knowledge and challenges.Covid-19 患者的功能能力和康复策略：当前的知识和挑战。
Rev Soc Bras Med Trop. 2021 Jan 29;54:e07892020. doi: 10.1590/0037-8682-0789-2020. eCollection 2021.
本文引用的文献
1
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
2
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.抗凝治疗的重症 COVID-19 患者中静脉血栓栓塞事件发生率高。
J Thromb Haemost. 2020 Jul;18(7):1743-1746. doi: 10.1111/jth.14869. Epub 2020 May 27.
3
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.COVID-19 急性呼吸窘迫综合征患者的促凝模式。
J Thromb Haemost. 2020 Jul;18(7):1747-1751. doi: 10.1111/jth.14854. Epub 2020 May 6.
4
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.新冠肺炎患者 ICU 中的高凝状态：血栓弹力描记图结果和其他止血参数报告。
J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.
5
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
6
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
7
Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation.脓毒症相关性凝血障碍与弥散性血管内凝血。
Semin Thromb Hemost. 2020 Feb;46(1):89-95. doi: 10.1055/s-0039-1694995. Epub 2019 Aug 23.
8
Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation.脓毒症诱导的凝血病和弥散性血管内凝血的诊断与管理
J Thromb Haemost. 2019 Nov;17(11):1989-1994. doi: 10.1111/jth.14578. Epub 2019 Aug 13.
9
Thromboelastometry in critically ill patients with disseminated intravascular coagulation.弥散性血管内凝血危重症患者的血栓弹力图检测
Blood Coagul Fibrinolysis. 2019 Jul;30(5):181-187. doi: 10.1097/MBC.0000000000000808.
10
Venous Thromboembolism: Advances in Diagnosis and Treatment.静脉血栓栓塞症：诊断与治疗的进展。
JAMA. 2018 Oct 16;320(15):1583-1594. doi: 10.1001/jama.2018.14346.
Zotero 插件